Two replication-defective adenoviral vaccine vectors for the induction of immune responses to PPRV

Vaccine

Volumn 32, Issue 3, 2014, Pages 393-400

  Rojas, José M ^a,c   Moreno, Héctor ^a   García, Aída ^b   Ramírez, Juan C ^b   Sevilla, Noemí ^a   Martín, Verónica ^a  

^a Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria Consejo Superior de Investigaciones Científicas   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Adenoviral vectors; Immune response; PPRV; Vaccines

Indexed keywords

ADENOVIRUS VECTOR; MEASLES VACCINE; NEUTRALIZING ANTIBODY; VIRUS FUSION PROTEIN; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN ADENOVIRUS 5; IMMUNOGENICITY; MEASLES VACCINATION; MEASLES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ADENOVIRAL VECTORS; IMMUNE RESPONSE; PPRV; VACCINES;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DRUG CARRIERS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED C57BL; PESTE-DES-PETITS-RUMINANTS; PESTE-DES-PETITS-RUMINANTS VIRUS; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 84891011793     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.11.033     Document Type: Article

References (54)

1. Lefevre P.C., Diallo A. Peste des petits ruminants. Rev Sci Tech 1990, 9:935-981.
2. El Hag Ali B., Taylor W.P. Isolation of peste des petits ruminants virus from the Sudan. Res Vet Sci 1984, 36(January (1)):1-4.
3. Elzein E.M., Housawi F.M., Bashareek Y., Gameel A.A., Al-Afaleq A.I., Anderson E. Severe PPR infection in gazelles kept under semi-free range conditions. J Vet Med B: Infect Dis Vet Public Health 2004, 51(March (2)):68-71.
4. Ozkul A., Akca Y., Alkan F., Barrett T., Karaoglu T., Dagalp S.B., et al. Prevalence, distribution, and host range of Peste des petits ruminants virus, Turkey. Emerg Infect Dis 2002, 8(July (7)):708-712.
5. Amjad H., Qamar ul I., Forsyth M., Barrett T., Rossiter P.B. Peste des petits ruminants in goats in Pakistan. Vet Rec 1996, 139(August (5)):118-119.
6. Kwiatek O., Minet C., Grillet C., Hurard C., Carlsson E., Karimov B., et al. Peste des Petits Ruminants (PPR) outbreak in Tajikistan. J Comp Pathol 2007, 136(2/3):9.
7. Wang Z., Bao J., Wu X., Liu Y., Li L., Liu C., et al. Peste des petits ruminants virus in Tibet, China. Emerg Infect Dis 2009, 15(February (2)):299-301.
8. Gibbs E.P., Taylor W.P., Lawman M.J., Bryant J. Classification of peste des petits ruminants virus as the fourth member of the genus Morbillivirus. Intervirology 1979, 11(5):268-274.
9. Jones L., Giavedoni L., Saliki J.T., Brown C., Mebus C., Yilma T. Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus. Vaccine 1993, 11(9):961-964.
10. Sinnathamby G., Renukaradhya G.J., Rajasekhar M., Nayak R., Shaila M.S. Immune responses in goats to recombinant hemagglutinin-neuraminidase glycoprotein of Peste des petits ruminants virus: identification of a T cell determinant. Vaccine 2001, 19(September (32)):4816-4823.
11. Merz D.C., Scheid A., Choppin P.W. Immunological studies of the functions of paramyxovirus glycoproteins. Virology 1981, 109(February (1)):94-105.
12. Diallo A., Minet C., Berhe G., Le Goff C., Black D.N., Fleming M., et al. Goat immune response to capripox vaccine expressing the hemagglutinin protein of peste des petits ruminants. Ann N Y Acad Sci 2002 October, 969:88-91.
13. Choppin P.W., Scheid A. The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis 1980, 2(January-February (1)):40-461.
14. Taylor W.P. Protection of goats against peste-des-petits-ruminants with attenuated rinderpest virus. Res Vet Sci 1979, 27(November (3)):321-324.
15. Qin J., Huang H., Ruan Y., Hou X., Yang S., Wang C., et al. A novel recombinant Peste des petits ruminants-canine adenovirus vaccine elicits long-lasting neutralizing antibody response against PPR in goats. PLoS One 2012, 7(5):e37170.
16. Saravanan P., Sen A., Balamurugan V., Rajak K.K., Bhanuprakash V., Palaniswami K.S., et al. Comparative efficacy of peste des petits ruminants (PPR) vaccines. Biologicals 2010, 38(July (4)):479-485.
17. Anderson J., McKay J.A. The detection of antibodies against peste des petits ruminants virus in cattle, sheep and goats and the possible implications to rinderpest control programmes. Epidemiol Infect 1994, 112(February (1)):225-231.
18. Diallo A., Minet C., Le Goff C., Berhe G., Albina E., Libeau G., et al. The threat of peste des petits ruminants: progress in vaccine development for disease control. Vaccine 2007, 25(July (30)):5591-5597.
19. Das S.C., Baron M.D., Barrett T. Recovery and characterization of a chimeric rinderpest virus with the glycoproteins of peste-des-petits-ruminants virus: homologous F and H proteins are required for virus viability. J Virol 2000, 74(October (19)):9039-9047.
20. Chen W., Hu S., Qu L., Hu Q., Zhang Q., Zhi H., et al. A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep. Vaccine 2010, 28(July (30)):4742-4750.
21. Berhe G., Minet C., Le Goff C., Barrett T., Ngangnou A., Grillet C., et al. Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections. J Virol 2003, 77(January (2)):1571-1577.
22. Tatsis N., Ertl H.C. Adenoviruses as vaccine vectors. Mol Ther 2004, 10(October (4)):616-629.
23. Jaiswal S., Khanna N., Swaminathan S. Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2. J Virol 2003, 77(December (23)):12907-12913.
24. Liu Y., Zhang S., Ma G., Zhang F., Hu R. Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine. Vaccine 2008, 26(October (42)):5368-5372.
25. Hu R., Zhang S., Fooks A.R., Yuan H., Liu Y., Li H., et al. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Microbes Infect 2006, 8(April (4)):1090-1097.
26. Croyle M.A., Patel A., Tran K.N., Gray M., Zhang Y., Strong J.E., et al. Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice. PLoS One 2008, 3(10):e3548.
27. Matthews Q.L., Fatima A., Tang Y., Perry B.A., Tsuruta Y., Komarova S., et al. HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach. PLoS One 2010, 5(7):e11815.
28. Hu R.L., Liu Y., Zhang S.F., Zhang F., Fooks A.R. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Vaccine 2007, 25(July (29)):5301-5307.
29. Charlton K.M., Artois M., Prevec L., Campbell J.B., Casey G.A., Wandeler A.I., et al. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Arch Virol 1992, 123(1/2):169-179.
30. Hahn K., DeBiasio R., Tishon A., Lewicki H., Gairin J.E., LaRocca G., et al. Antigen presentation and cytotoxic T lymphocyte killing studied in individual, living cells. Virology 1994, 201(June (2)):330-340.
31. Seki F., Ono N., Yamaguchi R., Yanagi Y. Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells. J Virol 2003, 77(September (18)):9943-9950.
32. Sambrook J., Russell D.W. Molecular cloning: a laboratory manual 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 3rd ed.
33. Seth S., Shaila M.S. The fusion protein of Peste des petits ruminants virus mediates biological fusion in the absence of hemagglutinin-neuraminidase protein. Virology 2001, 289(October (1)):86-94.
34. Barrett T., Belsham G.J., Subbarao S.M., Evans S.A. Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus. Virology 1989, 170(May (1)):11-18.
35. + T cell epitopes from the VP7 core protein in mouse and sheep. Vaccine 2011, 29(September (40)):6848-6857.
36. Babiuk L.A., Tikoo S.K. Adenoviruses as vectors for delivering vaccines to mucosal surfaces. J Biotechnol 2000, 83(September (1/2)):105-113.
37. Sun Y., Liu D.F., Wang Y.F., Liang B.B., Cheng D., Li N., et al. Generation and efficacy evaluation of a recombinant adenovirus expressing the E2 protein of classical swine fever virus. Res Vet Sci 2010, 88(February (1)):77-82.
38. Pacheco J.M., Brum M.C., Moraes M.P., Golde W.T., Grubman M.J. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 2005, 337(July (2)):205-209.
39. Wesley R.D., Lager K.M. Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus. Am J Vet Res 2005, 66(November (11)):1943-1947.
40. Fernandez E., Toledo J.R., Chiong M., Parra F., Rodriguez E., Montero C., et al. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration. Vet Immunol Immunopathol 2011, 142(August (3/4)):179-188.
41. Prevec L., Campbell J.B., Christie B.S., Belbeck L., Graham F.L. A recombinant human adenovirus vaccine against rabies. J Infect Dis 1990, 161(January (1)):27-30.
42. Prevec L., Schneider M., Rosenthal K.L., Belbeck L.W., Derbyshire J.B., Graham F.L. Use of human adenovirus-based vectors for antigen expression in animals. J Gen Virol 1989, 70(February (Pt. 2)):429-434.
43. Mayr G.A., Chinsangaram J., Grubman M.J. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 1999, 263(October (2)):496-506.
44. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 2007, 81(January (1)):150-158.
45. Weingartl H.M., Berhane Y., Caswell J.L., Loosmore S., Audonnet J.C., Roth J.A., et al. Recombinant nipah virus vaccines protect pigs against challenge. J Virol 2006, 80(August (16)):7929-7938.
46. Permar S.R., Klumpp S.A., Mansfield K.G., Carville A.A., Gorgone D.A., Lifton M.A., et al. Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. J Infect Dis 2004, 190(September (5)):998-1005.
47. van Els C.A., Nanan R. T cell responses in acute measles. Viral Immunol 2002, 15(3):435-450.
48. Permar S.R., Klumpp S.A., Mansfield K.G., Kim W.K., Gorgone D.A., Lifton M.A., et al. Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J Virol 2003, 77(April (7)):4396-4400.
49. Mitra-Kaushik S., Nayak R., Shaila M.S. Identification of a cytotoxic T-cell epitope on the recombinant nucleocapsid proteins of Rinderpest and Peste des petits ruminants viruses presented as assembled nucleocapsids. Virology 2001, 279(January (1)):210-220.
50. Sinnathamby G., Seth S., Nayak R., Shaila M.S. Cytotoxic T cell epitope in cattle from the attachment glycoproteins of rinderpest and peste des petits ruminants viruses. Viral Immunol 2004, 17(3):401-410.
51. Maeda K., West K., Hayasaka D., Ennis F.A., Terajima M. Recombinant adenovirus vector vaccine induces stronger cytotoxic T-cell responses than recombinant vaccinia virus vector, plasmid DNA, or a combination of these. Viral Immunol 2005, 18(4):657-667.
52. Pham N.L., Badovinac V.P., Harty J.T. A default pathway of memory CD8 T cell differentiation after dendritic cell immunization is deflected by encounter with inflammatory cytokines during antigen-driven proliferation. J Immunol 2009, 183(August (4)):2337-2348.
53. 2-inactivated whole-virus vaccine. J Virol 2012, 86(December (24)):13735-13744.
54. + CTL responses following adenovirus vaccination. PLoS One 2012, 7(10):e47004.